Advertisement

Critical Care Endocrinology

  • Colleen Veloski
  • Kathleen J. Brennan
Chapter

Abstract

After studying this chapter, you should be able to: Differentiate diabetic ketoacidosis from hyperglycemic hyperosmolar state and understand the management strategies for each disorder. Identify and treat thyroid disorders in the intensive care unit using clinical findings and laboratory data. Correctly determine the causes and treatments of the most common calcium disorders in the critical care unit. Know the clinical findings, diagnostic evaluations, and treatment of adrenocortical excess and insufficiency. Understand the pathogenesis and treatment of diabetes insipidus, and the syndrome of inappropriate antidiuretic hormone secretion.

Keywords

Diabetes Insipidus Adrenal Insufficiency Serum Osmolality Nephrogenic Diabetes Insipidus Central Pontine Myelinolysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kitabchi AE, Nyenwe EA. Hyperglycemic crisis in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin N Am. 2006;35:725-751.CrossRefGoogle Scholar
  2. 2.
    Magee MF, Bankim AB. Management of decompensated diabetes. Diabetic ketoacidosis and hyperosmolar hypergylcemic syndrome. Crit Care Clin. 2001;17(1):75-106.PubMedCrossRefGoogle Scholar
  3. 3.
    Kitabchi,AE, EA Nyenwe. Hyperglycemic Crisis in Diabetes Mellitus: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Endocrinol Metab Clin N Am 2006;35: 725-751.CrossRefGoogle Scholar
  4. 4.
    Kitabchi AE. BM Wall. Management of hyperglycemic crisis in patients with diabetes. Diabetes Care. 2001;24:131-153.PubMedCrossRefGoogle Scholar
  5. 5.
    Canaris GJ, Manoeitz N, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534.PubMedCrossRefGoogle Scholar
  6. 6.
    Wartofsky L. Myxedema coma. Endocrinol Metab Clin N Am. 2006;35:687-698.CrossRefGoogle Scholar
  7. 7.
    Zwillich CW, Pierson DJ, Hofeldt PD, et al. Ventilatory control in myxedema and hypothyroidism. New Engl J Med 1975;292: 662-665.PubMedCrossRefGoogle Scholar
  8. 8.
    Ringel MD. Management of hypothyroidism and hyperthyroidism in the intensive care unit. Crit Care Clin. 2001;17:59-74.PubMedCrossRefGoogle Scholar
  9. 9.
    Nabil N, Mimer DJ, Amatruda JM. Methimazole: an alternate route of administration. J Clin Endocrinol Metab. 1982;54(1):180-181.PubMedCrossRefGoogle Scholar
  10. 10.
    Hodak SP, Huang C, Clarke D, et al. Intraveneous methimazole in the treatment of refractory hyperthyroidism. Thyroid. 2006; 16:691.PubMedCrossRefGoogle Scholar
  11. 11.
    Solomon BL, Wartofsky L, Burman KD. Adjunctive cholestyra­mine therapy for throtoxicosis. Clin Endocrinol. 1983;38: 39-43.CrossRefGoogle Scholar
  12. 12.
    Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric, and biochemical features (Minisymposium). J Intern Med. 2005;257:6-17.PubMedCrossRefGoogle Scholar
  13. 13.
    Stewart AF. Hypercalcemia associated with cancer. N Engl J Med. 2005;352:373.PubMedCrossRefGoogle Scholar
  14. 14.
    Gabriely I, Leu JP, Barzel US. Back to basics. N Engl J Med. 2008;358:195.CrossRefGoogle Scholar
  15. 15.
    Gucalp R, Theriault R, Gill I, et al. Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone. Arch Intern Med. 1994;154(17):1935.PubMedCrossRefGoogle Scholar
  16. 16.
    Sawyer N, Newstead C, Drummond A, et al. Fast (4-h) or slow (24-h) infusions of pamidronate disodium (aminohydroxypropylidene diphosphonate (APD)) as single-shot treatment of hypercalcemia. Bone Miner. 1990;9(2):121.PubMedCrossRefGoogle Scholar
  17. 17.
    Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001;19:558.PubMedGoogle Scholar
  18. 18.
    Cvitkovic F, Armand JP, Tubiana-Hulin M. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia. Cancer J. 2006;12(1):47.PubMedCrossRefGoogle Scholar
  19. 19.
    Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005;90:135.PubMedCrossRefGoogle Scholar
  20. 20.
    Peter R, Mishra V, FraserWD. Severe hypocalcemia after being given intravenous bisphosphonate. BMJ. 2004;328:335-336.PubMedCrossRefGoogle Scholar
  21. 21.
    Shoback D. Hypoparathyroidism. NEJM. 2008;359:391.PubMedCrossRefGoogle Scholar
  22. 22.
    Hoffman E. The Chvostek sign:a clinical study. AM J Surg. 1958;96:33.PubMedCrossRefGoogle Scholar
  23. 23.
    Fonseca OA, Calverly JR. Neurologic manifestations of hypoparathyroidism. Arch Intern Med. 1967;120:202.PubMedCrossRefGoogle Scholar
  24. 24.
    Schaat M, Payne CA. Effect of diphenylhydantoin and phenobarbital on overt and latent tetany. N Engl J Med. 1996;274: 1228-1233Google Scholar
  25. 25.
    Dickerson RN, Alexander KH, Minard G, et al. Accuracy of methods to estimate ionized and corrected serum calcium concentrations in critically ill, multiple trauma patients receiving specialized nutrition support. J Parenter Enteral Nutr. 2004; 28(3):133-141.CrossRefGoogle Scholar
  26. 26.
    Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcemia. BMJ. 2008;336(7656):1298-1302PubMedCrossRefGoogle Scholar
  27. 27.
    Marik PE, Pastores SM, Annane D, Meduri GU, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937-1949.PubMedCrossRefGoogle Scholar
  28. 28.
    Loh JA, Verbalis JG. Disorders of water and salt metabolism associated with pituitary disease. Endocrinol Metab Clin N Am. 2008;37:213-234.CrossRefGoogle Scholar
  29. 29.
    Adler SM, Verbalis JG. Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin North Am. 2006;35(4): 873-894.PubMedCrossRefGoogle Scholar
  30. 30.
    Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. NEJM. 2007;356:2064-2072.PubMedCrossRefGoogle Scholar
  31. 31.
    Lauriat SM, Berl T. The hyponatremic patient: practical focus on therapy. J Am Soc Nephrol. 1997;8:1599-1607.PubMedGoogle Scholar
  32. 32.
    Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci. 2003;326:25-30.PubMedCrossRefGoogle Scholar

Additional Reading

  1. Kitabchi AE, Nyenwe EA. Hyperglycemic crisis in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin N Am. 2006;35:725-751.CrossRefGoogle Scholar
  2. Magee MF, Bankim AB. Management of decompensated diabetes. Diabetic ketoacidosis and hyperosmolar hypergylcemic syndrome. Crit Care Clin. 2001;17(1):75-106.PubMedCrossRefGoogle Scholar
  3. Kitabchi AE. BM Wall. Management of hyperglycemic crisis in patients with diabetes. Diabetes Care. 2001;24:131-153.PubMedCrossRefGoogle Scholar
  4. Wartofsky L. Myxedema Coma. Endocrinol Metab Clin N Am. 2006;35:687-698.CrossRefGoogle Scholar
  5. Ringel MD. Management of hypothyroidism and hyperthyroidism in the intensive care unit. Crit Care Clin. 2001;17:59-74.PubMedCrossRefGoogle Scholar
  6. Stewart AF. Hypercalcemia associated with cancer. N Engl J Med. 2005;352:373.PubMedCrossRefGoogle Scholar
  7. Shoback D. Hypoparathyroidism. N Engl J Med. 2008;359:391.PubMedCrossRefGoogle Scholar
  8. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937-1949.PubMedCrossRefGoogle Scholar
  9. Adler SM, Verbalis JG. Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin N Am. 2006;35(4):873-894.CrossRefGoogle Scholar
  10. Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064-2072.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Colleen Veloski
    • 1
  • Kathleen J. Brennan
    • 2
  1. 1.Temple University School of MedicinePhiladelphiaUSA
  2. 2.Division of Pulmonary and Critical Care MedicineTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations